Natriuretic peptides in the regulation of the hypothalamic-pituitary-adrenal axis

International Review of Cell and Molecular Biology

Volumn 280, Issue C, 2010, Pages 1-39

  Porzionato, Andrea ^a   Macchi, Veronica ^a   Rucinski, Marcin ^b   Malendowicz, Ludwik K ^b   De Caro, Raffaele ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

ACTH secretion; Catecholamine secretion; Hypothalamic pituitary adrenal axis; Natriuretic peptides; Pheochromocytomas

Indexed keywords

ADENYLATE CYCLASE; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR I 125; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC GMP; FOLLITROPIN; GLUCOCORTICOID; GONADORELIN; GUANYLATE CYCLASE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR C; NORADRENALIN; OXYTOCIN; UNCLASSIFIED DRUG; VASOPRESSIN;

ADRENAL CANCER; ADRENAL CELL; ADRENAL CORTEX; ADRENAL CORTEX CELL; ADRENAL GLAND; ADRENAL MEDULLA; ALDOSTERONE RELEASE; BOOK; BRAIN; CATECHOLAMINE RELEASE; CATECHOLAMINE UPTAKE; CIRCULATION; CORTICOSTEROID RELEASE; CUSHING SYNDROME; HORMONE RELEASE; HUMAN; HYPOPHYSIS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NEOPLASM; NONHUMAN; PATHOPHYSIOLOGY; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; SECRETION; SIGNAL TRANSDUCTION; SPECIES; ZONA GLOMERULOSA;

EID: 77957917725     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1937-6448(10)80001-2     Document Type: Article

References (279)

1. Abdelalim, E.M., Takada, T., Torii, R., Tooyama, I., 2006. Molecular cloning of BNP from heart and its immunohistochemical localization in the hypothalamus of monkey. Peptides 27, 1886-1893.
2. Agui, T., Kurihara, M., Saavedra, J.M., 1989. Multiple types of receptors for atrial natriuretic peptide. Eur. J. Pharmacol. 162, 301-307.
3. Akamatsu, N., Inenaga, K., Yamashita, H., 1993. Inhibitory effects of natriuretic peptides on VP neurons mediated through cGMP and cGMP-dependent protein kinase in vitro. J. Neuroendocrinol. 5, 517-522.
4. Anand-Srivastava, M.B., 2005. Natriuretic peptide receptor-C signaling and regulation. Peptides 26, 1044-1059.
5. Anand-Srivastava, M.B., Trachte, G.J., 1993. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol. Rev. 45, 455-497.
6. Antoni, F.A., Hunter, E.F., Lowry, P.J., Noble, J.M., Seckl, J.R., 1992. Atriopeptin: an endogenous corticotropin-release inhibiting hormone. Endocrinology 130, 1753-1755.
7. Antunes-Rodrigues, J., McCann, S.M., Rogers, L.C., Samson, W.K., 1985. Atrial natriuretic factor inhibits dehydration- and angiotensin II-induced water intake in the conscious, unrestrained rat. Proc. Natl. Acad. Sci. USA 82, 8720-8723.
8. Armando, I., Jezova, M., Bregonzio, C., Baiardi, G., Saavedra, J.M., 2004. Angiotensin II AT1 and AT2 receptor types regulate basal and stress-induced adrenomedullary catecholamine production through transcriptional regulation of tyrosine hydroxylase. Ann. N. Y. Acad. Sci. 1018, 302-309.
9. Atarashi, K., Mulrow, P.J., Franco-Saenz, R., Snajdar, R., Rapp, J., 1984. Inhibition of aldosterone production by an atrial extract. Science 224, 992-994.
10. Atlas, S.A., Maack, T., 1987. Effects of atrial natriuretic factor on the kidney and the reninangiotensin-aldosterone system. Endocrinol. Metab. Clin. North Am. 16, 107-143.
11. Babinski, K., Féthière, J., Roy, M., De Léan, A., Ong, H., 1992. C-type natriuretic peptide in bovine chromaffin cells. The regulation of its biosynthesis and secretion. FEBS Lett. 313, 300-302.
12. Babinski, K., Haddad, P., Vallerand, D., McNicoll, N., de Léan, A., Ong, H., 1995. Natriuretic peptides inhibit nicotine-induced whole-cell currents and catecholamine secretion in bovine chromaffin cells: evidence for the involvement of the atrial natriuretic factor R2 receptors. J. Neurochem. 64, 1080-1087.
13. Belloni, A.S., Neri, G., Andreis, P.G., Musajo, F.G., Gottardo, G., Mazzocchi, G., et al., 1993. A comparative study of the effect of atrial natriuretic peptide (ANP) on the secretory activity of rat adrenal cortex and angiotensin-II-responsive adrenocortical autotransplants. Exp. Toxicol. Pathol. 45, 341-344.
14. Bierwolf, C., Burgemeister, A., Luthke, K., Born, J., Fehm, H.L., 1998. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men. J. Clin. Endocrinol. Metab. 83, 1151-1157.
15. Biró, E., Gardi, J., Vecsernyés, M., Julesz, J., Tóth, G., Telegdy, G., 1996. The effects of atrial natriuretic peptide (ANP1-28) on corticotropin releasing factor in brain of rats. Life Sci. 59, 1351-1356.
16. Bodart, V., Rainey, W.E., Fournier, A., Ong, H., De Léan, A., 1996. The H295R human adrenocortical cell line contains functional atrial natriuretic peptide receptors that inhibit aldosterone biosynthesis. Mol. Cell Endocrinol. 118, 137-144.
17. Bodart, V., Babinski, K., Ong, H., De Léan, A., 1997. Comparative effect of pituitary adenylate cyclase-activating polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells. Endocrinology 138, 566-573.
18. Bormann, J., Flugge, G., Fuchs, E., 1989. Effect of atrial natriuretic factor (ANF) on nicotinic acetylcholine receptor channels in bovine chromaffin cells. Pflügers Arch. 414, 11-14.
19. Boumezrag, A., Lyall, F., Dow, J.A., 1988. Characterization of specific binding of atrial natriuretic peptide (ANP) to rat PC12 phaeochromocytoma cells. Life Sci. 43, 2035-2042.
20. Bowman, M.E., Robinson, P.J., Smith, R., 1997. Atrial natriuretic peptide, cyclic GMP analogues and modulation of guanylyl cyclase do not alter stimulated POMC peptide release from perifused rat or sheep corticotrophs. J. Neuroendocrinol. 9, 929-936.
21. Brown, J., Czarnecki, A., 1990. Autoradiographic localization of atrial and brain natriuretic peptide receptors in rat brain. Am. J. Physiol. 258, R57-R63.
22. Calle, R.A., Bollag, W.B., White, S., Betancourt-Calle, S., Kent, P., 2001. ANPs effect on MARCKS and StAR phosphorylation in agonist-stimulated glomerulosa cells. Mol. Cell. Endocrinol. 177, 71-79.
23. Cantin, M., Genest, J., 1985. The heart and the atrial natriuretic factor. Endocr. Rev. 6, 107-127.
24. Carr, B.R., Mason, J.I., 1988. The effects of alpha-human atrial natriuretic polypeptide on steroidogenesis by fetal zone cells of the human fetal adrenal gland. Am. J. Obstet. Gynecol. 159, 1361-1365.
25. Castrén, E., Saavedra, J.M., 1989. Lack of vasopressin increases hypothalamic atrial natriuretic peptide binding sites. Am. J. Physiol. 257, R168-R173.
26. Chai, S.Y., Sexton, P.M., Allen, A.M., Figdor, R., Mendelsohn, F.A.O., 1986. In vivo autoradiographic localization of ANP receptors in rat kidney and adrenal gland. Am. J. Physiol. 250, F753-F757.
27. Chang, M.S., Lowe, D.G., Lewis, M., Hellmiss, R., Chen, E., Goeddel, D.V., 1989. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 341, 68-72.
28. Charles, C.J., Richards, A.M., Espiner, E.A., 1992. Central C-type natriuretic peptide but not atrial natriuretic factor lowers blood pressure and adrenocortical secretion in normal conscious sheep. Endocrinology 131, 1721-1726.
29. Charles, C.J., Espiner, E.A., Richards, A.M., Donald, R.A., 1995. Central C-type natriuretic peptide augments the hormone response to hemorrhage in conscious sheep. Peptides 16, 129-132.
30. Chartier, L., Schiffrin, E., Thibault, G., Garcia, R., 1984. Atrial natriuretic factor inhibits the stimulation of aldosterone secretion by angiotensin II, ACTH and potassium in vitro and angiotensin II-induced steroidogenesis in vivo. Endocrinology 115, 2026-2028.
31. Chatelain, D., Lesage, J., Montel, V., Chatelain, A., Deloof, S., 2003. Effect of natriuretic peptides on in vitro stimulated adrenocorticotropic hormone release and pro-opiomelanocortin mRNA expression by the fetal rat pituitary gland in late gestation. Horm. Res. 59, 142-148.
32. Chen, Y.F., Elton, T.S., Oparil, S., 1992. Quantitation of hypothalamic atrial natriuretic peptide messenger RNA in hypertensive rats. Hypertension 19, 296-300.
33. Chen, Y.M., Wu, K.D., Hung, K.Y., Pu, Y.S., Hsieh, B.S., 1995. Quantitative analysis of messenger ribonucleic acid encoding natriuretic peptide receptors in aldosterone-producing adenoma. Mol. Cell. Endocrinol. 111, 139-146.
34. Cherradi, N., Brandenburger, Y., Rossier, M.F., Vallotton, M.B., Stocco, D.M., Capponi, A.M., 1998. Atrial natriuretic peptide inhibits calcium-induced steroidogenic acute regulatory protein gene transcription in adrenal glomerulosa cells. Mol. Endocrinol. 12, 962-972.
35. Chriguer, R.S., Rocha, M.J., Antunes-Rodrigues, J., Franci, C.R., 2001. Hypothalamic atrial natriuretic peptide and secretion of oxytocin. Brain Res. 889, 239-242.
36. Cozza, E.N., Foecking, M.F., Vila, M.C., Gomez-Sanchez, C.E., 1993. Adrenal receptors for natriuretic peptides and inhibition of aldosterone secretion in calf zona glomerulosa cells in culture. Acta Endocrinol. 129, 59-64.
37. Dagnino, L., Drouin, J., Nemer, M., 1991. Differential expression of natriuretic peptide genes in cardiac and extracardiac tissues. Mol. Endocrinol. 5, 1292-1300.
38. Dayanithi, G., Antoni, F.A., 1990. Atriopeptins are potent inhibitors of ACTH secretion by rat anterior pituitary cells in vitro: involvement of the atrial natriuretic factor receptor domain of membrane-bound guanylyl cyclase. J. Endocrinol. 125, 39-44.
39. De Léan, A., Gutkowska, J., McNicoll, N., Schiller, P.W., Cantin, M., Genest, J., 1984. Characterization of specific receptors for atrial natriuretic factor in bovine adrenal zona glomerulosa. Life Sci. 35, 2311-2318.
40. De Léan, A., Ong, H., McNicoll, N., Racz, K., Gutkowska, J., Cantin, M., 1985. Identification of aldosterone secretion inhibitory factor in bovine adrenal medulla. Life Sci. 36, 2375-2382.
41. Deloof, S., Chatelain, A., Dupouy, J.P., 1994. Characteristics and developmental changes of ANP-binding sites in rat adrenal glands during the perinatal period. Regul. Pept. 51, 199-206.
42. Deloof, S., De Seze, C., Montel, V., Chatelain, A., 1999. Effects of water deprivation on atrial natriuretic peptide secretion and density of binding sites in adrenal glands and kidneys of maternal and fetal rats in late gestation. Eur. J. Endocrinol. 141, 160-168.
43. Deloof, S., De Seze, C., Montel, V., Chatelain, A., 2000. Atrial natriuretic peptide and aldosterone secretions, and atrial natriuretic peptide-binding sites in kidneys and adrenal glands of pregnant and fetal rats in late gestation in response to a high-salt diet. Eur. J. Endocrinol. 142, 524-532.
44. Deloff, S., Leprêtre, A., Montel, V., Châtelain, A., 1992. Effect of rat atrial natriuretic factor on in vivo and in vitro aldosterone and corticosterone secretions in the rat during the perinatal period. Biol. Neonate 62, 145-154.
45. Denker, P.S., Vesely, D.L., Gómez-Sánchez, C.E., 1990. Effect of pro-atrial natriuretic peptides 1-30, 31-67 and 99-126 on angiotensin II-stimulated aldosterone production in calf adrenal cells. J. Steroid Biochem. Mol. Biol. 37, 617-619.
46. Duntas, L., Bornstein, S.R., Scherbaum, W.A., Holst, J.J., 1993. Atrial natriuretic peptidelike immunoreactive material (ANP-LI) is released from the adrenal gland by splanchnic nerve stimulation. Exp. Clin. Endocrinol. 101, 371-373.
47. Edwards, A.V., Ghatei, M.A., Bloom, S.R., 1990. The effect of splanchnic nerve stimulation on the uptake of atrial natriuretic peptide by the adrenal gland in conscious calves. J. Endocrinol. Invest. 13, 887-892.
48. Elliott, M.E., 1990. Phosphorylation of adrenal histone H3 is affected by angiotensin, ACTH, dibutyryl cAMP, and atrial natriuretic peptide. Life Sci. 46, 1479-1488.
49. Elliott, M.E., Goodfriend, T.L., Jefcoate, C.R., 1993. Bovine adrenal glomerulosa and fasciculata cells exhibit 28.5-kilodalton proteins sensitive to angiotensin, other agonists, and atrial natriuretic peptide. Endocrinology 133, 1669-1677.
50. Emori, T., Hirata, Y., Imai, T., Eguchi, S., Kanno, K., Marumo, F., 1993. Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells. Endocrinology 133, 2474-2480.
51. Engler, D., Pham, T., Liu, J.P., Fullerton, M.J., Clarke, I.J., Funder, J.W., 1990. Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with hypothalamic-pituitary disconnection. II. Evidence for in vivo ultradian hypersecretion of proopiome-lanocortin peptides by the isolated anterior and intermediate pituitary. Endocrinology 127, 1956-1966.
52. Fernandez, B.E., Vatta, M.S., Bianciotti, L.G., 1993. Comparative effects of bradykinin and atrial natriuretic factor on neuronal and non-neuronal noradrenaline uptake in the central nervous system of the rat. Arch. Int. Physiol. Biochim. Biophys. 101, 337-340.
53. Fernández, B.E., Leder, M., Fernández, G., Bianciotti, L.G., Vatta, M.S., 1997. Atrial natriuretic factor modifies the biosynthesis and turnover of norepinephrine in the rat adrenal medulla. Biochem. Biophys. Res. Commun. 238, 343-346.
54. Féthière, J., Graihle, R., Larose, L., Babinski, K., Ong, H., De Léan, A., 1993. Distribution and regulation of natriuretic factor-R1C receptor subtypes in mammalian cell lines. Mol. Cell. Biochem. 124, 11-16.
55. Fink, G., Dow, R.C., Casley, D., Johnston, C.I., Lim, A.T., Copolov, D.L., et al., 1991. Atrial natriuretic peptide is a physiological inhibitor of ACTH release: evidence from immunoneutralization in vivo. J. Endocrinol. 131, R9-R12.
56. Fowkes, R.C., McArdle, C.A., 2000. C-type natriuretic peptide: an important neuroendocrine regulator? Trends Endocrinol. Metab. 11, 333-338.
57. Fowkes, R.C., Forrest-Owen, W., Williams, B., McArdle, C.A., 1999. C-type natriuretic peptide (CNP) effects on intracellular calcium [Ca2{thorn}]i in mouse gonadotrope-derived alphaT3-1 cell line. Regul. Pept. 84, 43-49.
58. Franci, C.R., Anselmo-Franci, J.A., McCann, S.M., 1990. Opposite effects of central immunoneutralization of angiotensin II or atrial natriuretic peptide on luteinizing hormone release in ovariectomized rats. Neuroendocrinology 51, 683-687.
59. Franci, C.R., Anselmo-Franci, J.A., McCann, S.M., 1992. The role of endogenous atrial natriuretic peptide in resting and stress-induced release of corticotropin, prolactin, growth hormone, and thyroid-stimulating hormone. Proc. Natl. Acad. Sci. USA 89, 11391-11395.
60. Fuchs, E., Shigematsu, K., Saavedra, J.M., 1986. Binding sites of atrial natriuretic peptide in tree shrew adrenal gland. Peptides 7, 873-876.
61. Ganguly, A., 1992. Atrial natriuretic peptide-induced inhibition of aldosterone secretion: a quest for mediator(s). Am. J. Physiol. 263, E181-E194.
62. Ganz, M.B., Nee, J.J., Isales, C.M., Barrett, P.Q., 1994. Atrial natriuretic peptide enhances activity of potassium conductance in adrenal glomerulosa cells. Am. J. Physiol. 266, C1357-C1365.
63. Gardi, J., Bíró, E., Vecsernyés, M., Julesz, J., Nyári, T., Tóth, G., et al., 1997. The effects of brain and C-type natriuretic peptides on corticotropin-releasing factor in brain of rats. Life Sci. 60, 2111-2117.
64. Gardner, D.G., Vlasuk, G.P., Baxter, J.D., Fiddes, J.C., Lewicki, J.A., 1987. Identification of atrial natriuretic factor gene transcripts in the central nervous system of the rat. Proc. Natl. Acad. Sci. USA 84, 2175-2179.
65. Gerbes, A.L., Dagnino, L., Nguyen, T., Nemer, M., 1994. Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in human tissues. J. Clin. Endocrinol. Metab. 78, 1307-1311.
66. Gerstberger, R., Schütz, H., Luther-Dyroff, D., Keil, R., Simon, E., 1992. Inhibition of vasopressin and aldosterone release by atrial natriuretic peptide in conscious rabbits. Exp. Physiol. 77, 587-600.
67. Gibson, T.R., Wildey, G.M., Manaker, S., Glembotski, C.C., 1986. Autoradiographic localization and characterization of atrial natriuretic peptide binding sites in the rat central nervous system and adrenal gland. J. Neurosci. 6, 2004-2011.
68. Gilkes, A.F., MacKay, K.B., Cramb, G., Guild, S.B., 1992. Atrial natriuretic peptide effects in AtT-20 pituitary tumour cells. Mol. Cell. Endocrinol. 89, 39-45.
69. Gilkes, A.F., Ogden, P.H., Guild, S.B., Cramb, G., 1994. Characterization of natriuretic peptide receptor subtypes in the AtT-20 pituitary tumour cell line. Biochem. J. 299, 481-487.
70. Giridhar, J., Peoples, R.W., Isom, G.E., 1992. Modulation of hypothalamic norepinephrine release by atrial natriuretic peptide: involvement of cyclic GMP. Eur. J. Pharmacol. 213, 317-321.
71. Glembotski, C.C., Wildey, G.M., Gibson, T.R., 1985. Molecular forms of immunoactive atrial natriuretic peptide in the rat hypothalamus and atrium. Biochem. Biophys. Res. Commun. 129, 671-678.
72. Grandclément, B., Brisson, C., Bayard, F., Tremblay, J., Gossard, F., Morel, G., 1995. Localization of mRNA coding for the three subtypes of atrial natriuretic factor (ANF) receptors in rat anterior pituitary gland cells. J. Neuroendocrinol. 7, 939-948.
73. Grandclément, B., Ronsin, B., Morel, G., 1997. The three subtypes of atrial natriuretic peptide (ANP) receptors are expressed in the rat adrenal gland. Biol. Cell. 89, 29-41.
74. Grossman, A., Costa, A., Navarra, P., Tsagarakis, S., 1993. The regulation of hypothalamic corticotropin-releasing factor release: in vitro studies. Ciba Found. Symp. 172, 129-150.
75. Guild, S.B., Cramb, G., 1999. Characterisation of the effects of natriuretic peptides upon ACTH secretion from the mouse pituitary. Mol. Cell. Endocrinol. 152, 11-19.
76. Gundlach, A.L., Knobe, K.E., 1992. Distribution of preproatrial natriuretic peptide mRNA in rat brain detected by in situ hybridization of DNA oligonucleotides: enrichment in hypothalamic and limbic regions. J. Neurochem. 59, 758-761.
77. Gutkowska, J., Racz, K., Debinski, W., Thibault, G., Garcia, R., Kuchel, O., Cantin, M., Genest, J., 1987. An atrial natriuretic factor-like activity in rat posterior hypophysis. Peptides 8, 461-465.
78. Gutkowska, J., Cantin, M., 1988. Bioactive atrial natriuretic factor-like peptides in rat anterior pituitary. Can. J. Physiol. Pharmacol. 66, 270-275.
79. Gutkowska, J., Antunes-Rodrigues, J., McCann, S.M., 1997. Atrial natriuretic peptide in brain and pituitary gland. Physiol. Rev. 77, 465-515.
80. Hartmann, M., Skryabin, B.V., Müller, T., Gazinski, A., Schröter, J., Gassner, B., et al., 2008. Alternative splicing of the guanylyl cyclase-A receptor modulates atrial natriuretic peptide signaling. J. Biol. Chem. 283, 28313-28320.
81. Hartt, D.J., Ogiwara, T., Ho, A.K., Chik, C.L., 1995. Cyclic GMP stimulates growth hormone release in rat anterior pituitary cells. Biochem. Biophys. Res. Commun. 214, 918-926.
82. Hashiguchi, T., Higuchi, K., Ohashi, M., Takayanagi, R., Matsuo, H., Nawata, H., 1989. Effect of porcine brain natriuretic peptide (pBNP) on human adrenocortical steroido-genesis. Clin. Endocrinol. 31, 623-630.
83. Hashimoto, K., Hattori, T., Suemaru, S., Sugawara, M., Takao, T., Kageyama, J., et al., 1987. Atrial natriuretic peptide does not affect corticotropin-releasing factor-, arginine vasopressin- and angiotensin II-induced adrenocorticotropic hormone release in vivo or in vitro. Regul. Pept. 17, 53-60.
84. Heisler, S., Tallerico-Melnyk, T., Yip, C., Schimmer, B.P., 1989. Y-1 adrenocortical tumor cells contain atrial natriuretic peptide receptors which regulate cyclic nucleotide metabolism and steroidogenesis. Endocrinology 125, 2235-2243.
85. Herman, J.P., Langub Jr., M.C., Watson Jr., R.E., 1993. Localization of C-type natriuretic peptide mRNA in rat hypothalamus. Endocrinology 133, 1903-1906.
86. Herman, J.P., Dolgas, C.M., Rucker, D., Langub Jr., M.C., 1996a. Localization of natriuretic peptide-activated guanylate cyclase mRNAs in the rat brain. J. Comp. Neurol. 369, 165-187.
87. Herman, J.P., Dolgas, C.M., Marcinek, R., Langub Jr., M.C., 1996b. Expression and glucocorticoid regulation of natriuretic peptide clearance receptor (NPR-C) mRNA in rat brain and choroid plexus. J. Chem. Neuroanat. 11, 257-265.
88. Higuchi, K., Hashiguchi, T., Ohashi, M., Takayanagi, R., Haji, M., Matsuo, H., et al., 1989. Porcine brain natriuretic peptide receptor in bovine adrenal cortex. Life Sci. 44, 881-886.
89. Hirata, Y., Tomita, M., Yoshimi, H., Kuramochi, M., Ito, K., Ikeda, M., 1985. Effect of synthetic human atrial natriuretic peptide on aldosterone secretion by dispersed aldosterone-producing adenoma cells in vitro. J. Clin. Endocrinol. Metab. 61, 677-680.
90. Horvath, J., Ertl, T., Schally, A.V., 1986. Effect of atrial natriuretic peptide on gonadotropin release in superfused rat pituitary cells. Proc. Natl. Acad. Sci. USA 83, 3444-3446.
91. Huang, F.L.S., Skala, K.D., Samson, W.K., 1992a. C-type natriuretic peptide stimulates prolactin secretion by a hypothalamic site of action. J. Neuroendocrinol. 4, 593-597.
92. Huang, F.L.S., Skala, K.D., Samson, W.K., 1992b. Hypothalamic effects of C-type natriuretic peptide on luteinizing hormone secretion. J. Neuroendocrinol. 4, 325-330.
93. Ibanez-Santos, J., Tsagarakis, S., Rees, L.H., Besser, G.M., Grossman, A., 1990. Atrial natriuretic peptides inhibit the release of corticotrophin-releasing factor-41 from the rat hypothalamus in vitro. J. Endocrinol. 126, 223-228.
94. Iitake, K., Share, L., Crofton, J.T., Brooks, D.P., Ouchi, Y., Blaine, E.H., 1986. Central atrial natriuretic factor reduces vasopressin secretion in the rat. Endocrinology 119, 438-440.
95. Ikeda, Y., Tanaka, I., Oki, Y., Ikeda, Y., Yoshimi, T., 1989. Effect of atrial natriuretic peptide on the release of beta-endorphin from rat hypothalamo-neurohypophysial complex. Endocrinol. Jpn. 36, 647-653.
96. Isales, C.M., Bollag, W.B., Kiernan, L.C., Barrett, P.Q., 1989. Effect of ANP on sustained aldosterone secretion stimulated by angiotensin II. Am. J. Physiol. 256, C89-C95.
97. Isales, C.M., Lewicki, J.A., Nee, J.J., Barrett, P.Q., 1992. ANP-(7-23) stimulates a DHP-sensitive Ca2+ conductance and reduces cellular cAMP via a cGMP-independent mechanism. Am. J. Physiol. 263, C334-C342.
98. Itoh, H., Nakao, K., Saito, Y., Yamada, T., Shirakami, G., Mukoyama, M., et al., 1989. Radioimmunoassay for brain natriuretic peptide (BNP) detection of BNP in canine brain. Biochem. Biophys. Res. Commun. 158, 120-128.
99. Jaiswal, N., Paul, A.K., Jaiswal, R.K., Sharma, R.K., 1986. Atrial natriuretic factor regulation of cyclic GMP levels and steroidogenesis in isolated fasciculata cells of rat adrenal cortex. FEBS Lett. 199, 121-124.
100. Jakubik, P., Janota, T., Widimsky Jr., J., Zelinka, T., Strauch, B., Petrak, O., et al., 2006. Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration. Blood Press. 15, 302-307.
101. Jankowski, M., Marcinkiewicz, M., Bouanga, J.C., Gutkowska, J., 2004. Changes of atrial natriuretic peptide in rat supraoptic neurones during pregnancy. J. Neuroendocrinol. 16, 441-449.
102. Januszewicz, P., Thibault, G., Garcia, R., Gutkowska, J., Genest, J., Cantin, M., 1986. Effect of synthetic atrial natriuretic factor on arginine vasopressin release by the rat hypothalamo-neurohypophysial complex in organ culture. Biochem. Biophys. Res. Commun. 134, 652-658.
103. Jászberényi, M., Bujdosó, E., Telegdy, G., 1998. Effects of C-type natriuretic peptide on pituitary-adrenal activation in rats. Neuroreport 9, 2601-2603.
104. Jászberényi, M., Bujdosó, E., Telegdy, G., 2000. Effects of brain natriuretic peptide on pituitary-adrenal activation in rats. Life Sci. 66, 1655-1661.
105. Jirikowski, G.F., Back, H., Forssmann, W.G., Stumpf, W.E., 1986. Coexistence of atrial natriuretic factor (ANF) and oxytocin in neurons of the rat hypothalamus. Neuropeptides 8, 243-249.
106. Kadowaki, K., Hirota, K., Koike, K., Ohmichi, M., Miyake, A., Tanizawa, O., 1992. Atrial and brain natriuretic peptides enhance dopamine accumulation in cultured rat hypothalamic cells including dopaminergic neurons. Neuroendocrinology 56, 11-17.
107. Kaneko, T., Shirakami, G., Nakao, K., Nagata, I., Nakagawa, O., Hama, N., et al., 1993. C-type natriuretic peptide (CNP) is the major natriuretic peptide in human cerebrospinal fluid. Brain Res. 612, 104-109.
108. Kangawa, K., Matsuo, H., 1984. Purification and complete amino acid sequence of alphahuman atrial natriuretic polypeptide (alpha-hANP). Biochem. Biophys. Res. Commun. 118, 131-139.
109. Kato, J., Etoh, T., Kitamura, K., Eto, T., 2005. Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism. Am. J. Hypertens. 18, 354-357.
110. Kawai, M., Naruse, M., Yoshimoto, T., Naruse, K., Shionoya, K., Tanaka, M., et al., 1996. C-type natriuretic peptide as a possible local modulator of aldosterone secretion in bovine adrenal zona glomerulosa. Endocrinology 137, 42-46.
111. Kawata, M., Ueda, S., Nakao, K., Morii, N., Kiso, Y., Imura, H., et al., 1985. Immuohistochemical demonstration of alpha-atrial natriretic plypeptide-containing neurons in the rat brain. Histochemistry 83, 1-3.
112. Kellner, M., Wiedemann, K., Holsboer, F., 1992. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci. 50, 1835-1842.
113. King, M.S., Baertschi, A.J., 1989. Physiological concentrations of atrial natriuretic factors with intact N-terminal sequences inhibit corticotropin-releasing factor-stimulated adrenocorticotropin secretion from cultured anterior pituitary cells. Endocrinology 124, 286-292.
114. Kobayashi, H., Niina, H., Yamamoto, R., Wada, A., 1998. Receptors for natriuretic peptides in adrenal chromaffin cells. Biochem. Pharmacol. 55, 1-7.
115. Komatsu, Y., Nakao, K., Suga, S., Ogawa, Y., Mukoyama, M., Arai, H., et al., 1991. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology 129, 1104-1106.
116. Komatsu, K., Tanaka, I., Funai, T., Ichiyama, A., Yoshimi, T., 1992. Increased level of atrial natriuretic peptide messenger RNA in the hypothalamus and brainstem of spontaneously hypertensive rats. J. Hypertens. 10, 17-23.
117. Konrad, E.M., Thibault, G., Schiffrin, E.L., 1992. Autoradiographic visualization of the natriuretic peptide receptor-B in rat tissues. Regul. Pept. 39, 177-189.
118. Kovács, K.J., Antoni, F.A., 1990. Atriopeptin inhibits stimulated secretion of adrenocorti-cotropin in rats: evidence for a pituitary site of action. Endocrinology 127, 3003-3008.
119. Kudo, T., Baird, A., 1984-1985. Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor. Nature 312, 756-757.
120. Kuhn, M., 2003. Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ. Res. 93, 700-709.
121. Kurihara, M., Saavedra, J.M., Shigematsu, K., 1987. Localization and characterization of atrial natriuretic peptide binding sites in discrete areas of rat brain and pituitary gland by quantitative autoradiography. Brain Res. 408, 31-39.
122. Lai, F.J., Shin, S.J., Lee, Y.J., Lin, S.R., Jou, W.Y., Tsai, J.H., 2000. Up-regulation of adrenal cortical and medullary atrial natriuretic peptide and gene expression in rats with deoxycorticosterone acetate-salt treatment. Endocrinology 141, 325-332.
123. Lange, D.L., Haywood, J.R., Hinojosa-Laborde, C., 2000. Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 35, 385-390.
124. Langub Jr., M.C., Dolgas, C.M., Watson Jr., R.E., Herman, J.P., 1995. The C-type natriuretic peptide receptor is the predominant natriuretic peptide receptor mRNA expressed in rat hypothalamus. J. Neuroendocrinol. 7, 305-309.
125. Lapinski, M., Stepniakowski, K., Januszewicz, A., Wocial, B., Chodakowska, J., Feltynowski, T., et al., 1991. Plasma atrial natriuretic peptide concentration in patients with primary aldosteronism. J. Hypertens. Suppl. 9, S260-S261.
126. Lee, J., Malvin, R.L., Claybaugh, J.R., Huang, B.S., 1987. Atrial natriuretic factor inhibits vasopressin secretion in conscious sheep. Proc. Soc. Exp. Biol. Med. 185, 272-276.
127. Lee, Y.J., Lin, S.R., Shin, S.J., Tsai, J.H., 1993. Increased adrenal medullary atrial natriuretic polypeptide synthesis in patients with primary aldosteronism. J. Clin. Endocrinol. Metab. 76, 1357-1362.
128. Lee, Y.J., Lin, S.R., Shin, S.J., Lai, Y.H., Lin, Y.T., Tsai, J.H., 1994. Brain natriuretic peptide is synthesized in the human adrenal medulla and its messenger ribonucleic acid expression along with that of atrial natriuretic peptide are enhanced in patients with primary aldosteronism. J. Clin. Endocrinol. Metab. 79, 1476-1482.
129. Levin, E.R., Gardner, D.G., Samson, W.K., 1998. Natriuretic peptides. N. Engl. J. Med. 339, 321-328.
130. Lewandowska, A., Szyburska, I., Guzek, J.W., 1992. Atrial natriuretic peptide inhibits neurohypophysial hormones' release in the rat (in vitro and in vivo studies). J. Physiol. Pharmacol. 43, 79-88.
131. Liang, F., Kapoun, A.M., Lam, A., Damm, D.L., Quan, D., O'Connell, M., et al., 2007. B-Type natriuretic peptide inhibited angiotensin II-stimulated cholesterol biosynthesis, cholesterol transfer, and steroidogenesis in primary human adrenocortical cells. Endocrinology 148, 3722-3729.
132. Lightly, E.R., Walker, S.W., Bird, I.M., Williams, B.C., 1990. Subclassification of beta-adrenoceptors responsible for steroidogenesis in primary cultures of bovine adrenocortical zona fasciculata/reticularis cells. Br. J. Pharmacol. 99, 709-712.
133. Lim, A.T., Dow, R.C., Yang, Z., Fink, G., 1994. ANP(5-28) is the major molecular species in hypophysial portal blood of the rat. Peptides 15, 1557-1559.
134. Lipari, F.E., Lipari, D., Dieli, F., Valentino, B., 2005. Atrial natriuretic peptide secretion during development of the rat supraoptic nucleus. Eur. J. Histochem. 49, 379-384.
135. Lipari, E.F., Lipari, A., Dieli, F., Valentino, B., 2007. ANP presence in the hypothalamic suprachiasmatic nucleus of developing rat. Ital. J. Anat. Embryol. 112, 19-25.
136. Lloyd, R.V., Qian, X., Jin, L., Ruebel, K., Bayliss, J., Zhang, S., et al., 2005. Analysis of pituitary cells by laser capture microdissection. Methods Mol. Biol. 293, 233-241.
137. Lotshaw, D.P., Franco-Saenz, R., Mulrow, P.J., 1991. Atrial natriuretic peptide inhibition of calcium ionophore A23187-stimulated aldosterone secretion in rat adrenal glomerulosa cells. Endocrinology 129, 2305-2310.
138. Luckman, S.M., Bicknell, R.J., 1991. Binding sites for atrial natriuretic peptide (ANP) on cultured pituicytes: lack of effect of ANP on release of neurohypophysial hormones in vitro. Neurosci. Lett. 123, 156-159.
139. Lynch, D.R., Braas, K.M., Snyder, S.H., 1986. Atrial natriuretic factor receptors in rat kidney, adrenal gland, and brain: autoradiographic localization and fluid balance dependent changes. Proc. Natl. Acad. Sci. USA 83, 3557-3561.
140. Maack, T., 1992. Receptors of atrial natriuretic factor. Annu. Rev. Physiol. 54, 11-27.
141. MacFarland, R.T., Zelus, B.D., Beavo, J.A., 1991. High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells. J. Biol. Chem. 266, 136-142.
142. Makino, S., Hashimoto, K., Hirasawa, R., Hattori, T., Kageyama, J., Ota, Z., 1990. Central interaction between endothelin and brain natriuretic peptide on pressor and hormonal responses. Brain Res. 534, 117-121.
143. Makino, S., Hashimoto, K., Hirasawa, R., Hattori, T., Ota, Z., 1992. Central interaction between endothelin and brain natriuretic peptide on vasopressin secretion. J. Hypertens. 10, 25-28.
144. Malendowicz, L.K., Andreis, P.G., Markowska, A., Nowak, M., Warchol, J.B., Neri, G., et al., 1994. Effects of neuromedin U-8 on the secretory activity of the rat adrenal cortex: evidence for an indirect action requiring the presence of the zona medullaris. Res. Exp. Med. 194, 69-79.
145. Malendowicz, L.K., Brelinska, R., De Caro, R., Trejer, M., Nussdorfer, G.G., 1998. Endothelin-1, acting via the A receptor subtype, stimulates thymocyte proliferation in the rat. Life Sci. 62, 1959-1963.
146. Malendowicz, L.K., Guidolin, D., Trejter, M., Rucinski, M., Porzionato, A., De Caro, R., et al., 2009. Neuromedin-U inhibits unilateral adrenalectomy-induced compensatory adrenal growth in the rat. Peptides 30, 935-939.
147. Mantero, F., Rocco, S., Pertile, F., Carpenè, G., Fallo, F., Leone, L., et al., 1987. Effect of alpha-human atrial natriuretic peptide in low renin essential hypertension and primary aldosteronism. Clin. Exp. Hypertens. A 9, 1505-1513.
148. Mantyh, C.R., Kruger, L., Brecha, N.C., Mantyh, P.W., 1986. Localization of specific binding sites for atrial natriuretic factor in peripheral tissues of the guinea pig, rat, and human. Hypertension 8, 712-721.
149. Mantyh, C.R., Kruger, L., Brecha, N.C., Mantyh, P.W., 1987. Localization of specific binding sites for atrial natriuretic factor in the central nervous system of rat, guinea pig, cat and human. Brain Res. 412, 329-342.
150. Manzanares, J., Lookingland, K.J., Moore, K.E., 1990. Atrial natriuretic peptide-induced suppression of basal and dehydration-induced vasopressin secretion is not mediated by hypothalamic tuberohypophysial or tuberoinfundibular dopaminergic neurons. Brain Res. 527, 103-108.
151. Maurer, R., Reubi, J.C., 1986. Distribution and coregulation of three peptide receptors in adrenals. Eur. J. Pharmacol. 125, 241-247.
152. Mazzocchi, G., Rebuffat, P., Nussdorfer, G.G., 1987. Atrial natriuretic factor (ANF) inhibits the growth and the secretory activity of rat adrenal zona glomerulosa in vivo. J. Steroid Biochem. 28, 643-646.
153. Mazzocchi, G., Gottardo, G., Nussdorfer, G.G., 1998. Paracrine control of steroid hormone secretion by chromaffin cells in the adrenal gland of lower vertebrates. Histol. Histopathol. 13, 209-220.
154. McArdle, C.A., Poch, A., Käppler, K., 1993. Cyclic guanosine monophosphate production in the pituitary: stimulation by C-type natriuretic peptide and inhibition by gonadotropin-releasing hormone in alpha T3-1 cells. Endocrinology 132, 2065-2072.
155. McArdle, C.A., Olcese, J., Schmidt, C., Poch, A., Kratzmeier, M., Middendorff, R., 1994. C-type natriuretic peptide (CNP) in the pituitary: is CNP an autocrine regulator of gonadotropes? Endocrinology 135, 2794-2801.
156. McCann, S.M., Franci, C., Gutkowska, J., Favaretto, A.L., Antunes-Rodrigues, J., 1996. Neural control of atrial natriuretic peptide actions on fluid intake and excretion. Proc. Soc. Exp. Biol. Med. 213, 117-127.
157. McCarthy, R.T., Isales, C.M., Bollag, W.B., Rasmussen, H., Barrett, P.Q., 1990. Atrial natriuretic peptide differentially modulates T- and L-type calcium channels. Am. J. Physiol. 258, F473-F478.
158. McKenzie, J.C., Tanaka, I., Misono, K.S., Inagami, T., 1985. Immunocytochemical localization of atrial natriuretic factor in the kidney, adrenal medulla, pituitary, and atrium of rat. J. Histochem. Cytochem. 33, 828-832.
159. Melo, L.G., Veress, A.T., Ackermann, U., Pang, S.C., Flynn, T.G., Sonnenberg, H., 1999. Chronic hypertension in ANP knockout mice: contribution of peripheral resistance. Regul. Pept. 79, 109-115.
160. Mendelsohn, F.A., Allen, A.M., Chai, S.Y., Sexton, P.M., Figdor, R., 1987. Overlapping distributions of receptors for atrial natriuretic peptide and angiotensin II visualized by in vitro autoradiography: morphological basis of physiological antagonism. Can. J. Physiol. Pharmacol. 65, 1517-1521.
161. Middendorff, R., Paust, H.J., Davidoff, M.S., Olcese, J., 1997. Synthesis of C-type natriuretic peptide (CNP) by immortalized LHRH cells. J. Neuroendocrinol. 9, 177-182.
162. Minamino, N., Aburaya, M., Kojima, M., Miyamoto, K., Kangawa, K., Matsuo, H., 1993. Distribution of C-type natriuretic peptide and its messenger RNA in rat central nervous system and peripheral tissue. Biochem. Biophys. Res. Commun. 197, 326-335.
163. Moga, M.M., Saper, C.B., 1994. Neuropeptide-immunoreactive neurons projecting to the paraventricular hypothalamic nucleus in the rat. J. Comp. Neurol. 346, 137-150.
164. Morel, G., Chabot, J.G., Garcia-Caballero, T., Gossard, F., Dihl, F., Belles-Isles, M., et al., 1988. Synthesis, internalization, and localization of atrial natriuretic peptide in rat adrenal medulla. Endocrinology 123, 149-158.
165. Morel, G., Chabot, J.G., Gossard, F., Heisler, S., 1989a. Is atrial natriuretic peptide synthesized and internalized by gonadotrophs? Endocrinology 124, 1703-1710.
166. Morel, G., Mesguich, P., Chabot, J.G., Belles-Isles, M., Jeandel, L., Heisler, S., 1989b. Internalization of atrial natriuretic peptide by adrenal glomerulosa cells. Biol. Cell. 65, 181-188.
167. Mulay, S., Vaillancourt, P., Omer, S., Varma, D.R., 1995. Hormonal modulation of atrial natriuretic factor receptors in adrenal fasciculata cells from female rats. Can. J. Physiol. Pharmacol. 73, 140-144.
168. Mulligan, R.S., Livesey, J.H., Evans, M.J., Ellis, M.J., Donald, R.A., 1997. Atrial natriuretic peptide and C-type natriuretic peptide do not acutely inhibit the release of adrenocorticotropin from equine pituitary cells in vitro. Neuroendocrinology 65, 64-69.
169. Murakami, Y., Kato, Y., Tojo, K., Inoue, T., Yanaihara, N., Imura, H., 1988. Stimulation of growth hormone secretion by central administration of atrial natriuretic polypeptide in the rat. Endocrinology 122, 2103-2108.
170. Nagase, M., Katafuchi, T., Hirose, S., Fujita, T., 1997. Tissue distribution and localization of natriuretic peptide receptor subtypes in stroke-prone spontaneously hypertensive rats. J. Hypertens. 15, 1235-1243.
171. Nakamaru, M., Ogihara, T., Saito, H., Rakugi, H., Hashizume, K., Yamatodani, A., et al., 1989. Effect of atrial natriuretic peptide on catecholamine release from human pheochromocytoma. Acta Endocrinol. 120, 107-112.
172. Naruse, M., Obana, K., Naruse, K., Yamaguchi, H., Demura, H., Inagami, T., et al., 1987. Atrial natriuretic polypeptide inhibits cortisol secretion as well as aldosterone secretion in vitro from human adrenal tissue. J. Clin. Endocrinol. Metab. 64, 10-16.
173. Naruse, M., Takeyama, Y., Tanabe, A., Hiroshige, J., Naruse, K., Yoshimoto, T., et al., 1994. Atrial and brain natriuretic peptides in cardiovascular diseases. Hypertension 23, I231-I234.
174. Nawata, H., Ohashi, M., Haji, M., Takayanagi, R., Higuchi, K., Fujio, N., et al., 1991. Atrial and brain natriuretic peptide in adrenal steroidogenesis. J. Steroid Biochem. Mol. Biol. 40, 367-379.
175. Neuser, D., Stasch, J.P., Knorr, A., Kazda, S., 1993. Inhibition by atrial natriuretic peptide of endothelin-1-stimulated proliferation of vascular smooth-muscle cells. J. Cardiovasc. Pharmacol. 22 (Suppl 8), S257-S261.
176. Nguyen, T.T., Babinski, K., Ong, H., De Lean, A., 1990. Differential regulation of natriuretic peptide biosynthesis in bovine adrenal chromaffin cells. Peptides 11, 973-978.
177. Niina, H., Kobayashi, H., Yamamoto, R., Yuhi, T., Yanagita, T., Wada, A., 1996. Receptors for atrial natriuretic peptide in adrenal chromaffin cells. Biochem. Pharmacol. 51, 855-858.
178. Nikolaev, V.O., Gambaryan, S., Engelhardt, S., Walter, U., Lohse, M.J., 2005. Real-time monitoring of the PDE2 activity of live cells: hormone-stimulated cAMP hydrolysis is faster than hormone-stimulated cAMP synthesis. J. Biol. Chem. 280, 1716-1719.
179. Nilaver, G., Rosenbaum, L.C., Fukui, K., Neuwelt, E.A., Samson, W.K., Zimmerman, E.A., et al., 1989. An antiserum to atrial natriuretic factor (ANF) cross-reacts with neurophysins in the hypothalamo-neurohypophysial system of rat brain. Neuropeptides 14, 137-144.
180. Nunez, D.J., Davenport, A.P., Brown, M.J., 1990. Atrial natriuretic factor mRNA and binding sites in the adrenal gland. Biochem. J. 271, 555-558.
181. Nussdorfer, G.G., 1996. Paracrine control of adrenal cortical function by medullary chromaffin cells. Pharmacol. Rev. 48, 495-530.
182. Nussdorfer, G.G., 2001. Proadrenomedullin-derived peptides in the paracrine control of the hypothalamo-pituitary-adrenal axis. Int. Rev. Cytol. 206, 249-284.
183. Nussdorfer, G.G., Malendowicz, L.K., 1998a. Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 19, 1443-1467.
184. Nussdorfer, G.G., Malendowicz, L.K., 1998b. Role of tachykinins in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 19, 949-968.
185. Nussdorfer, G.G., Mazzocchi, G., Meneghelli, V., 1988-1989. Effect of atrial natriuretic factor (ANF) on the secretory activity of zona glomerulosa in sodium-restricted rats. Endocr. Res. 14, 293-303.
186. Nussdorfer, G.G., Rossi, G.P., Malendowicz, L.K., Mazzocchi, G., 1999. Autocrine-paracrine endothelin system in the physiology and pathology of steroid-secreting tissues. Pharmacol. Rev. 51, 403-438.
187. Obana, K., Naruse, M., Inagami, T., Brown, A.B., Naruse, K., Kurimoto, F., et al., 1985. Atrial natriuretic factor inhibits vasopressin secretion from rat posterior pituitary. Biochem. Biophys. Res. Commun. 132, 1088-1094.
188. Ohashi, M., Higuchi, K., Hashiguchi, T., Takayanagi, R., Nawata, H., 1991. Decreased binding capacity for alpha-human atrial natriuretic peptide in aldosterone-producing adrenocortical adenoma. Fukuoka Igaku Zasshi 82, 101-104.
189. Ohta, S., Shimekake, Y., Nagata, K., 1993. Cell-type-specific function of the C-type natriuretic peptide gene promoter in rat anterior pituitary-derived cultured cell lines. Mol. Cell. Biol. 13, 4077-4086.
190. Okuya, S., Yamashita, H., 1987. Effects of atrial natriuretic polypeptide on rat hypothalamic neurones in vitro. J. Physiol. 389, 717-728.
191. Olcese, J., Middendorff, R., Münker, M., Schmidt, C., McArdle, C.A., 1994. Natriuretic peptides stimulate cyclic GMP production in an immortalized LHRH neuronal cell line. J. Neuroendocrinol. 6, 127-130.
192. Oparil, S., Chen, Y.F., Peng, N., Wyss, J.M., 1996. Anterior hypothalamic norepinephrine, atrial natriuretic peptide, and hypertension. Front. Neuroendocrinol. 17, 212-246.
193. O'Sullivan, A.J., Burgoyne, R.D., 1990. Cyclic GMP regulates nicotine-induced secretion from cultured bovine adrenal chromaffin cells: effects of 8-bromo-cyclic GMP, atrial natriuretic peptide, and nitroprusside (nitric oxide). J. Neurochem. 54, 1805-1808.
194. O'Tierney, P.F., Tse, M.Y., Pang, S.C., 2007. Elevated renal norepinephrine in proANP gene-disrupted mice is associated with increased tyrosine hydroxylase expression in sympathetic ganglia. Regul. Pept. 143, 90-96.
195. Palkovits, M., Eskay, R.L., Antoni, F.A., 1987. Atrial natriuretic peptide in the median eminence is of paraventricular nucleus origin. Neuroendocrinology 46, 542-544.
196. Pandey, K.N., 2009. Ligand-mediated endocytosis and intracellular sequestration of guanylyl cyclase/natriuretic peptide receptors: role of GDAY motif. Mol. Cell. Biochem. 2009 Nov 26 [Epub ahead of print].
197. Papouchado, M.L., Vatta, M.S., Bianciotti, L.G., Fernández, B.E., 1995. Effects of atrial natriuretic factor on norepinephrine release evoked by angiotensins II and III in the rat adrenal medulla. Arch. Physiol. Biochem. 103, 55-58.
198. Pemberton, C.J., Yandle, T.G., Espiner, E.A., 2002. Immunoreactive forms of natriuretic peptides in ovine brain: response to heart failure. Peptides 23, 2235-2244.
199. Peng, N., Oparil, S., Meng, Q.C., Wyss, J.M., 1996. Atrial natriuretic peptide regulation of noradrenaline release in the anterior hypothalamic area of spontaneously hypertensive rats. J. Clin. Invest. 98, 2060-2065.
200. Perras, B., Schultes, B., Behn, B., Dodt, C., Born, J., Fehm, H.L., 2004. Intranasal atrial natriuretic peptide acts as central nervous inhibitor of the hypothalamo-pituitary-adrenal stress system in humans. J. Clin. Endocrinol. Metab. 89, 4642-4648.
201. Poole, C.J., Carter, D.A., Vallejo, M., Lightman, S.L., 1987. Atrial natriuretic factor inhibits the stimulated in-vivo and in-vitro release of vasopressin and oxytocin in the rat. J. Endocrinol. 112, 97-102.
202. Potter, L.R., Abbey-Hosch, S., Dickey, D.M., 2006. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr. Rev. 27, 47-72.
203. Potter, L.R., Yoder, A.R., Flora, D.R., Antos, L.K., Dickey, D.M., 2009. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb. Exp. Pharmacol. 191, 341-366.
204. Raha, D., Tortorella, C., Neri, G., Prasad, A., Raza, B., Raskar, R., et al., 2006. Atrial natriuretic peptide enhances cortisol secretion from guinea-pig adrenal gland: evidence for an indirect paracrine mechanism probably involving the local release of medullary catecholamines. Int. J. Mol. Med. 17, 633-636.
205. Raidoo, D.M., Narotam, P.K., van Dellen, J., Bhoola, K.D., 1998. Cellular orientation of atrial natriuretic peptide in the human brain. J. Chem. Neuroanat. 14, 207-213.
206. Rebuffat, P., Mazzocchi, G., Gottardo, G., Meneghelli, V., Nussdorfer, G.G., 1988. Further investigations on the atrial natriuretic factor (ANF)-induced inhibition of the growth and steroidogenic capacity of rat adrenal zona glomerulosa in vivo. J. Steroid Biochem. 29, 605-609.
207. Richard, D., Bourque, C.W., 1996. Atrial natriuretic peptide modulates synaptic transmission from osmoreceptor afferents to the supraoptic nucleus. J. Neurosci. 16, 7526-7532.
208. Rocco, S., Opocher, G., D'Agostino, D., Leone, L., Mantero, F., 1989. Lack of aldosterone inhibition by atrial natriuretic factor in primary aldosteronism: in vitro studies. J. Endocrinol. Invest. 12, 13-17.
209. Rodriguez Fermepin, M., Vatta, M.S., Bianciotti, L.G., Wolovich, T.J., Fernandez, B.E., 2000. B-type and C-type natriuretic peptides modify norepinephrine uptake in discrete encephalic nuclei of the rat. Cell. Mol. Neurobiol. 20, 763-771.
210. Rodriguez Lopez, P., Ehlerding, A., Leonhardt, S., Jarry, H., Wuttke, W., 1993. Effects of angiotensin II and atrial natriuretic peptide on LH release are exerted in the preoptic area: possible involvement of gamma-aminobutyric acid (GABA). Exp. Clin. Endocrinol. 101, 350-355.
211. Rodriguez-Pascual, F., Miras-Portugal, M.T., Torres, M., 1996. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase. Mol. Pharmacol. 49, 1058-1070.
212. Rose, R.A., Anand-Srivastava, M.B., Giles, W.R., Bains, J.S., 2005. C-type natriuretic peptide inhibits L-type Ca2+ current in rat magnocellular neurosecretory cells by activating the NPR-C receptor. J. Neurophysiol. 94, 612-621.
213. Ryan, M.C., Gundlach, A.L., 1998. Ontogenic expression of natriuretic peptide mRNAs in postnatal rat brain: implications for development? Brain Res. Dev. Brain Res. 105, 251-268.
214. Ryan, M.C., Shen, P.J., Gundlach, A.L., 1997. Angiotensinogen and natriuretic peptide mRNAs in rat brain: localization and differential regulation by adrenal steroids in hypothalamus. Peptides 18, 495-504.
215. Samson, W.K., 1985. Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. Neuroendocrinology 40, 277-279.
216. Samson, W.K., Bianchi, R., 1988. Further evidence for a hypothalamic site of action of atrial natriuretic factor: inhibition of prolactin secretion in the conscious rat. Can. J. Physiol. Pharmacol. 66, 301-305.
217. Samson, W.K., Skala, K.D., Huang, F.L., 1991. CNP-22 stimulates, rather than inhibits, water drinking in the rat: evidence for a unique biological action of the C-type natriuretic peptides. Brain Res. 568, 285-288.
218. Samson, W.K., Alexander, B.D., Skala, K.D., Huang, F.L., Fulton, R.J., 1992. Central peptidergic mechanisms controlling reproductive hormone secretion: novel methodology reveals a role for the natriuretic peptides. Can. J. Physiol. Pharmacol. 70, 773-778.
219. Samson, W.K., Huang, F.L., Fulton, R.J., 1993. C-type natriuretic peptide mediates the hypothalamic actions of the natriuretic peptides to inhibit luteinizing hormone secretion. Endocrinology 132, 504-509.
220. Samson, W.K., Huang, F.L., Fulton, R.J., 1995. Opposing neuroendocrine actions of the natriuretic peptides: C-type and A-type natriuretic peptides do not interact with the same hypothalamic cells controlling prolactin secretion. J. Neuroendocrinol. 7, 759-763.
221. Saper, C.B., Hurley, K.M., Moga, M.M., Holmes, H.R., Adams, S.A., Leahy, K.M., et al., 1989. Brain natriuretic peptides: differential localization of a new family of neuropeptides. Neurosci. Lett. 96, 29-34.
222. Sarzani, R., Opocher, G., Paci, M.V., Belloni, A.S., Mantero, F., Dessì-Fulgheri, P., et al., 1999. Natriuretic peptides receptors in human aldosterone-secreting adenomas. J. Endocrinol. Invest. 22, 514-518.
223. Scott, J.N., Jennes, L.H., 1989. Ontogeny of atrial natriuretic peptide receptors in fetal rat kidney and adrenal gland. Histochemistry 91, 395-400.
224. Segal, J.P., Stallings, N.R., Lee, C.E., Zhao, L., Socci, N., Viale, A., et al., 2005. Use of laser-capture microdissection for the identification of marker genes for the ventromedial hypothalamic nucleus. J. Neurosci. 25, 4181-4188.
225. Sessions, C., Lawrence, D., Clinkingbeard, C., Shenker, Y., 1992. Regulation of adrenal atrial natriuretic hormone receptor subtypes. Life Sci. 50, 1087-1095.
226. Shibasaki, T., Naruse, M., Naruse, K., Masuda, A., Kim, Y.S., Imaki, T., et al., 1986a. Atrial natriuretic factor is released from rat hypothalamus in vitro. Biochem. Biophys. Res. Commun. 136, 590-595.
227. Shibasaki, T., Naruse, M., Yamauchi, N., Masuda, A., Imaki, T., Naruse, K., et al., 1986b. Rat atrial natriuretic factor suppresses proopiomelanocortin-derived peptides secretion from both anterior and intermediate lobe cells and growth hormone release from anterior lobe cells of rat pituitary in vitro. Biochem. Biophys. Res. Commun. 135, 1035-1041.
228. Shimekake, Y., Ohta, S., Nagata, K., 1994. C-type natriuretic peptide stimulates secretion of growth hormone from rat-pituitary-derived GH3 cells via a cyclic-GMP-mediated pathway. Eur. J. Biochem. 222, 645-650.
229. Shionoiri, H., Hirawa, N., Takasaki, I., Ishikawa, Y., Minamisawa, K., Miyajima, E., et al., 1987. Presence of functional receptors for atrial natriuretic peptide in human pheochromocytoma. Biochem. Biophys. Res. Commun. 148, 286-291.
230. Shionoiri, H., Hirawa, N., Takasaki, I., Ishikawa, Y., Oda, H., Gotoh, E., et al., 1988. Lack of atrial natriuretic peptide receptors in human aldosteronoma. Biochem. Biophys. Res. Commun. 152, 37-43.
231. Shionoiri, H., Hirawa, N., Takasaki, I., Ishikawa, Y., Oda, H., Minamisawa, K., et al., 1989. Functional atrial natriuretic peptide receptor in human adrenal tumor. J. Cardiovasc. Pharmacol. 13 (Suppl 6), S9-S12.
232. Shirakami, G., Itoh, H., Suga, S., Komatsu, Y., Hama, N., Mori, K., et al., 1993. Central action of C-type natriuretic peptide on vasopressin secretion in conscious rats. Neurosci. Lett. 159, 25-28.
233. Simard, J., Hubert, J.F., Labrie, F., Israël-Assayag, E., Heisler, S., 1986. Atrial natriuretic factor-induced cGMP accumulation in rat anterior pituitary cells in culture is not coupled to hormonal secretion. Regul. Pept. 15, 269-278.
234. Sone, M., Totsune, K., Takahashi, K., Ohneda, M., Itoi, K., Murakami, O., et al., 1991. Porcine brain natriuretic peptide-like immunoreactivity in rat tissues. Peptides 12, 1333-1335.
235. Spiessberger, B., Bernhard, D., Herrmann, S., Feil, S., Werner, C., Luppa, P.B., et al., 2009. cGMP-dependent protein kinase II and aldosterone secretion. FEBS J. 276, 1007-1013.
236. Spinazzi, R., Andreis, P.G., Nussdorfer, G.G., 2005. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions. Int. J. Mol. Med. 15, 3-13.
237. Standaert, D.G., Needleman, P., Saper, C.B., 1986a. Organization of atriopeptin-like immunoreactive neurons in the central nervous system of the rat. J. Comp. Neurol. 253, 315-341.
238. Standaert, D.G., Cicero, T., Needleman, P., 1986b. Atriopeptin inhibits the release of luteinizing hormone. Fed. Proc. 45, 174.
239. Standaert, D.G., Cechetto, D.F., Needleman, P., Saper, C.B., 1987. Inhibition of the firing of vasopressin neurons by atriopeptin. Nature 329, 151-153.
240. Steele, M.K., 1990. Additive effects of atrial natriuretic peptide and angiotensin II on luteinizing hormone and prolactin release in female rats. Neuroendocrinology 51, 345-350.
241. Stepniakowski, K., Januszewicz, A., Lapiński, M., Feltynowski, T., Chodakowska, J., Ignatowska-Switalska, H., et al., 1992. Plasma atrial natriuretic peptide (ANP) concentration in patients with pheochromocytoma. Blood Press. 1, 157-161.
242. Stewart, R.E., Swithers, S.E., Plunkett, L.M., McCarty, R., 1988. ANF receptors: distribution and regulation in central and peripheral tissues. Neurosci. Biobehav. Rev. 12, 151-168.
243. Sudoh, T., Kangawa, K., Minamino, N., Matsuo, H., 1988. A new natriuretic peptide in porcine brain. Nature 332, 78-81.
244. Sudoh, T., Minamino, N., Kangawa, K., Matsuo, H., 1990. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168, 863-870.
245. Sumners, C., Tang, W., 1992. Atrial natriuretic peptide receptor subtypes in rat neuronal and astrocyte glial cultures. Am. J. Physiol. 262, C1134-C1143.
246. Takahashi, K., Totsune, K., Sone, M., Ohneda, M., Murakami, O., Itoi, K., et al., 1992. Human brain natriuretic peptide-like immunoreactivity in human brain. Peptides 13, 121-123.
247. Takao, T., Hashimoto, K., Ota, Z., 1988. Effect of atrial natriuretic peptide on acetylcholine-induced release of corticotropin-releasing factor from rat hypothalamus in vitro. Life Sci. 42, 1199-1203.
248. Tan, T.T., Yang, Z., Huang, W., Lim, A.T., 1994. ANF(1-28) is a potent suppressor of proopiomelanocortin (POMC) mRNA but a weak inhibitor of beta EP-LI release from AtT-20 cells. J. Endocrinol. 143, R1-R4.
249. Tanaka, I., Inagami, T., 1986. Release of immunoreactive atrial natriuretic factor from rat hypothalamus in vitro. Eur. J. Pharmacol. 122, 353-355.
250. Tanaka, I., Misono, K.S., Inagami, T., 1984. Atrial natriuretic factor in rat hypothalamus, atria and plasma: determination by specific radioimmunoassay. Biochem. Biophys. Res. Commun. 124, 663-668.
251. Thompson, I.R., Chand, A.N., Jonas, K.C., Burrin, J.M., Steinhelper, M.E., WheelerJones, C.P., et al., 2009. Molecular characterisation and functional interrogation of a local natriuretic peptide system in rodent pituitaries, alphaT3-1 and LbetaT2 gonadotroph cells. J. Endocrinol. 203, 215-229.
252. Totsune, K., Takahashi, K., Ohneda, M., Itoi, K., Murakami, O., Mouri, T., 1994a. C-type natriuretic peptide in the human central nervous system: distribution and molecular form. Peptides 15, 37-40.
253. Totsune, K., Takahashi, K., Murakami, O., Itoi, K., Sone, M., Ohneda, M., et al., 1994b. Immunoreactive C-type natriuretic peptide in human adrenal glands and adrenal tumors. Peptides 15, 287-290.
254. Totsune, K., Takahashi, K., Murakami, O., Satoh, F., Sone, M., Ohneda, M., et al., 1996. Immunoreactive brain natriuretic peptide in human adrenal glands and adrenal tumors. Eur. J. Endocrinol. 135, 352-356.
255. Trejter, M., Markowska, A., Belloni, A.S., Nussdorfer, G.G., Malendowicz, L.K., 2002. Investigation of the effect of different regulatory peptides on adrenocortical cell proliferation in immature rats: evidence that endogenous adrenomedullin exerts a stimulating action. Int. J. Mol. Med. 10, 81-84.
256. Tsutsui, M., Yanagihara, N., Minami, K., Kobayashi, H., Nakashima, Y., Kuroiwa, A., et al., 1994. C-type natriuretic peptide stimulates catecholamine synthesis through the accumulation of cyclic GMP in cultured bovine adrenal medullary cells. J. Pharmacol. Exp. Ther. 268, 584-589.
257. Tunny, T.J., Gordon, R.D., 1986. Plasma atrial natriuretic peptide in primary aldosteronism (before and after treatment) and in Bartter's and Gordon's syndromes. Lancet 1, 272-273.
258. Tunny, T.J., Jonsson, J.R., Klemm, S.A., Ballantine, D.M., Stowasser, M., Gordon, R.D., 1994. Association of restriction fragment length polymorphism at the atrial natriuretic peptide gene locus with aldosterone responsiveness to angiotensin in aldosterone-producing adenoma. Biochem. Biophys. Res. Commun. 204, 1312-1317.
259. Ueda, S., Minamino, N., Sudoh, T., Kangawa, K., Matsuo, H., 1988. Regional distribution of immunoreactive brain natriuretic peptide in porcine brain and spinal cord. Biochem. Biophys. Res. Commun. 155, 733-739.
260. Ur, E., Faria, M., Tsagarakis, S., Anderson, J.V., Besser, G.M., Grossman, A., 1991. Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjects. J. Endocrinol. 131, 163-167.
261. Vaillancourt, P., Omer, S., Palfree, R., Varma, D.R., Mulay, S., 1997. Downregulation of adrenal atrial natriuretic peptide receptor mRNAs and proteins by pregnancy in rats. J. Endocrinol. 155, 523-530.
262. Vatta, M.S., Bianciotti, L.G., Fernández, B.E., 1992. Effects of atrial natriuretic peptide, angiotensin II and III on norepinephrine uptake in the rat adrenal medulla. Rev. Esp. Fisiol. 48, 185-189.
263. Vatta, M.S., Papouchado, M.L., Bianciotti, L.G., Fernandez, B.E., 1994. Modulation of the rat adrenal medulla norepinephrine secretion in a sodium-free medium by atrial natriuretic factor. Peptides 15, 709-712.
264. Vatta, M., Rodriguez-Fermepín, M., Bianciotti, L., Perazzo, J., Monserrat, A., Fernández, B., 1995. Atrial natriuretic factor enhances norepinephrine uptake in circumventricular organs, locus coeruleus and nucleus tractus solitarii of the rat. Neurosci. Lett. 197, 29-32.
265. Vatta, M.S., Presas, M., Bianciotti, L.G., Zarrabeitia, V., Fernández, B.E., 1996. B and C types natriuretic peptides modulate norepinephrine uptake and release in the rat hypothalamus. Regul. Pept. 65, 175-184.
266. Vatta, M.S., Presas, M.F., Bianciotti, L.G., Rodriguez-Fermepin, M., Ambros, R., Fernandez, B.E., 1997. B and C types natriuretic peptides modify norepinephrine uptake and release in the rat adrenal medulla. Peptides 18, 1483-1489.
267. Vatta, M.S., Rubio, M., Bianciotti, L.G., Fernandez, B.E., 1998. Atrial natriuretic factor does not affect norepinephrine catabolism in rat hypothalamus and adrenal medulla. Neurosci. Lett. 253, 151-154.
268. Vatta, M.S., Rodriguez-Fermepin, M., Durante, G., Bianciotti, L.G., Fernandez, B.E., 1999. Atrial natriuretic factor inhibits norepinephrine biosynthesis and turnover in the rat hypothalamus. Regul. Pept. 85, 101-107.
269. Vesely, D.L., Chiou, S., Douglass, M.A., McCormick, M.T., Rodriguez-Paz, G., Schocken, D.D., 1995. Kaliuretic peptide and long acting natriuretic peptide as well as atrial natriuretic factor inhibit aldosterone secretion. J. Endocrinol. 146, 373-380.
270. Wiedemann, K., Jahn, H., Kellner, M., 2000. Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour. Exp. Clin. Endocrinol. Diabetes 108, 5-13.
271. Wilcox, J.N., Augustine, A., Goeddel, D.V., Lowe, D.G., 1991. Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol. Cell. Biol. 11, 3454-3462.
272. Wolfensberger, M., Forssmann, W.G., Reinecke, M., 1995. Localization and coexistence of atrial natriuretic peptide (ANP) and neuropeptide Y (NPY) in vertebrate adrenal chromaffin cells immunoreactive to TH, DBH and PNMT. Cell Tissue Res. 280, 267-276.
273. Wong, M., Samson, W.K., Dudley, C.A., Moss, R.L., 1986. Direct, neuronal action of atrial natriuretic factor in the rat brain. Neuroendocrinology 44, 49-53.
274. Yamaji, T., Ishibashi, M., Sekihara, H., Takaku, F., Nakaoka, H., Fujii, J., 1986. Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension. J. Clin. Endocrinol. Metab. 63, 815-818.
275. Yamamoto, S., Inenaga, K., Eto, S., Yamashita, H., 1995. Cardiovascular-related peptides influence hypothalamic neurons involved in control of body water homeostasis. Obes. Res. 3 (Suppl. 5), 789S-794S.
276. Yamamoto, S., Morimoto, I., Yanagihara, N., Kangawa, K., Inenaga, K., Eto, S., et al., 1997. C-type natriuretic peptide suppresses arginine-vasopressin secretion from dissociated magnocellular neurons in newborn rat supraoptic nucleus. Neurosci. Lett. 229, 97-100.
277. Yanagihara, N., Okazaki, M., Terao, T., Uezono, Y., Wada, A., Izumi, F., 1991. Stimulatory effects of brain natriuretic peptide on cyclic GMP accumulation and tyrosine hydroxylase activity in cultured bovine adrenal medullary cells. Naunyn. Schmiedebergs Arch. Pharmacol. 343, 289-295.
278. Yandle, T.G., Fisher, S., Charles, C., Espiner, E.A., Richards, A.M., 1993. The ovine hypothalamus and pituitary have markedly different distribution of C-type natriuretic peptide forms. Peptides 14, 713-716.
279. Yen, S.H., Pan, J.T., 1997. Atrial natriuretic peptide negatively modulates the stimulatory effects of angiotensin II on tuberoinfundibular dopaminergic neuronal activity. Neurochemical and electrophysiological studies. Neuroendocrinology 66, 313-320.